Intelligence Platform

Patents

Browse 379 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8334273

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324366

Compositions and methods for delivering RNAI using lipoproteins

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324368

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318693

Compositions and methods for inhibiting expression of mutant EGFR gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293719

iRNA agents targeting VEGF

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288525

Compositions and methods for inhibiting expression of CD45 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273869

Lipid formulated dsRNA targeting the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273870

Compositions and methods for inhibiting expression of a mutant gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273868

Compositions and methods for inhibiting viral replication

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268799

Compositions and methods for inhibiting expression of the HAMP gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263572

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227188

Enhancement of influenza gene expression

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222222

Compositions and methods for inhibiting expression of the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202980

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8188061

RNAi modulation of APOB and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183362

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168776

Method for making a 21 nucleotide double stranded RNA chemically linked at one end

Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168775

Compositions and methods for inhibiting expression of transthyretin

Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163711

Compositions and methods for inhibiting expression of the HAMP gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8158773

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8158601

Lipid formulation

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148344

Compositions and methods for mediating RNAi in vivo

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143390

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119608

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted